Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
NCT05826678
Summary
This study aims to understand the use of continuous glucose monitors (CGM) in Asian Americans with type 2 diabetes (T2D). Researchers will compare participants on continuous glucose monitors with participants using fingerstick self-monitoring with the aim of answering the following questions: 1. Check if continuous glucose monitoring is doable and consistent for this group, and see how it affects their quality of life. 2. Estimate how well the health outcomes (glucose and lipid markers) vary over the study period. 3. Understand how social and community factors can impact the use of continuous glucose monitors in this group.
Eligibility
Inclusion Criteria: * Chinese Americans 40 years and older who are 1st generation immigrants, currently residing in the US, and clinically diagnosed with T2D. * CGM-naïve * HbA1c \>7.5% within 3 months of study commencement. * Participants should also possess a smartphone, as this is needed in order to facilitate the collection of CGM data by the study team as well as homogenize CGM usage education. Exclusion Criteria: * Known diagnosis of dysfunction/dementia or learning disabilities * Not fluent in either English or Chinese * Currently undergoing or planning to undergo diathermy or high-frequency heat treatments in whom CGM use may be contraindicated * Inability to travel due to frailty or health reasons * Lack of internet access * Critically ill populations, including those on dialysis * Vulnerable populations (prisoners and women who are pregnant or planning to be pregnant during the time of study)
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05826678